Pediatric Drugs SCIE

國際簡稱：PEDIATR DRUGS 參考譯名：兒科藥物

主要研究方向：PEDIATRICS-PHARMACOLOGY & PHARMACY 非預警期刊審稿周期： 12周，或約稿

《兒科藥物》(Pediatric Drugs)是一本由Springer International Publishing出版的以PEDIATRICS-PHARMACOLOGY & PHARMACY為研究特色的國際期刊，發(fā)表該領域相關的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領域相關理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領域科學信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預警名單。

3區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
52 年發(fā)文量
3.4 IF影響因子
未開放 是否OA
55 H-index
1999 創(chuàng)刊年份
6 issues per year 出版周期
English 出版語言

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:

-overviews of contentious or emerging issues.

-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.

-practical reviews covering optimum drug management of specific clinical situations.

-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.

-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

[ 查看全部 ]

投稿咨詢加急咨詢

Pediatric Drugs期刊信息

ISSN：1174-5878
出版語言：English
是否OA：未開放
E-ISSN：1179-2019
出版地區(qū)：NEW ZEALAND
是否預警：否
出版商：Springer International Publishing
出版周期：6 issues per year
創(chuàng)刊時間：1999
開源占比：0.2356
Gold OA文章占比：29.27%
OA被引用占比：0.2235...
出版國人文章占比：0.02
出版撤稿占比：0
研究類文章占比：44.23%

Pediatric Drugs CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.2

1.017

1.263

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Pediatrics, Perinatology and Child Health	Q1	27 / 330	91%
大類：Medicine 小類：Pharmacology (medical)	Q1	50 / 272	81%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Pediatric Drugs中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	2區(qū) 3區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	2區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	2區(qū) 2區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	4區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)

中科院 2021年12月基礎版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	4區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 4區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	4區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	PEDIATRICS 兒科 PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)

Pediatric Drugs JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：PEDIATRICS	SCIE	Q1	19 / 186	90.1%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.5%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：PEDIATRICS	SCIE	Q1	39 / 186	79.3%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	78 / 354	78.11%

Pediatric Drugs歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Pediatric Drugs中國學者發(fā)文選摘

1、Trends in Adverse Drug Reactions Among Children: Evidence from Jiangsu Province of China, 2010-2019
Author: Xue, Hui; Li, Ming; Fan, Lijun; Du, Wei; Zou, Jianjun

Journal: PEDIATRIC DRUGS. 2023; Vol. 25, Issue 1, pp. 97-114. DOI: 10.1007/s40272-022-00539-6
2、Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives
Author: Zhao, Jinxia; Bian, Jialu; Zhao, Yinyu; Li, Yuanyuan; Liu, Boyu; Hao, Xu; He, Shiyu; Huang, Lin

Journal: PEDIATRIC DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40272-023-00560-3
3、Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
Author: Noor B. Almandil, Ying Liu, Macey L. Murray, Frank M. C. Besag, Katherine J. Aitchison, Ian C. K. Wong

Journal: PEDIATRIC DRUGS, 2013, Vol.15, 139-150, DOI:10.1007/s40272-013-0016-6
4、The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
Author: Xin Xiao, Wei Wang, Zhen Wang

Journal: PEDIATRIC DRUGS, 2014, Vol.16, 503-512, DOI:10.1007/s40272-014-0095-z
5、Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial
Author: Shuanghong Luo, Mengdong Ran, Qiuhong Luo, Min Shu, Qin Guo, Yu Zhu, Xiaoping Xie, Chongfan Zhang, Chaomin Wan

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 479-486, DOI:10.1007/s40272-017-0237-1
6、Effectiveness and Safety of Different Once-Daily Doses of Adrenocorticotropic Hormone for Infantile Spasms
Author: Jinghua Yin, Qianjin Lu, Fei Yin, Ying Wang, Fang He, Liwen Wu, Lifen Yang, Xiaolu Deng, Chen Chen, Jing Peng

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 357-365, DOI:10.1007/s40272-017-0225-5
7、Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
Author: Yuwen Wang, Yi Xu, Runmei Zou, Lijia Wu, Ping Liu, Hong Yang, Zhenwu Xie, Cheng Wang

Journal: PEDIATRIC DRUGS, 2018, Vol.20, 285-290, DOI:10.1007/s40272-018-0284-2
8、Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma
Author: Yuncui Yu, Lulu Jia, Yao Meng, Lihua Hu, Yiwei Liu, Xiaolu Nie, Meng Zhang, Xuan Zhang, Sheng Han, Xiaoxia Peng, Xiaoling Wang

Journal: PEDIATRIC DRUGS, 2017, Vol.20, 195-204, DOI:10.1007/s40272-017-0278-5